Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-16 Purchase | 2025-05-19 4:06 pm | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 10,000 | $5.9 | $59,000 | 36,500 (Direct) | View |
| 2025-05-14 Purchase | 2025-05-15 4:06 pm | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 10,000 | $5.445 | $54,450 | 26,500 (Direct) | View |
| 2024-08-20 Purchase | 2024-08-21 4:32 pm | EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director | 2,567 | $7.79 | $19,997 | 9,967 (Direct) | View |
| 2024-08-21 Purchase | 2024-08-21 4:01 pm | EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director | 5,000 | $7.95 | $39,750 | 13,150 (Direct) | View |
| 2024-08-19 Purchase | 2024-08-21 4:01 pm | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 12,500 | $7.98 | $99,750 | 16,500 (Direct) | View |
| 2024-08-16 Purchase | 2024-08-20 4:04 pm | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 3,173 | $7.88 | $25,003 | 224,524 (Indirect Direct) | View |
| 2024-07-12 Sale | 2024-07-16 4:24 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $10.06 | $116,995 | 11,625 (Direct) | View |
| 2024-06-03 Sale | 2024-06-04 4:28 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $10.3 | $119,705 | 23,250 (Direct) | View |
| 2024-05-14 Sale | 2024-05-16 5:19 pm | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 11,625 | $12.65 | $147,045 | 34,875 (Direct) | View |
| 2024-05-06 Purchase | 2024-05-08 4:23 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 850,000 | $11.86 | $10,081,721 | 8,325,000 (Indirect) | View |
| 2024-04-18 Purchase | 2024-04-22 4:00 pm | EyePoint Pharmaceuticals Inc. | EYPT | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP 10% Owner | 581,765 | $18.03 | $10,489,446 | 7,475,000 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-07-02 Gift | 2025-07-02 4:05 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 464,042 | $0 | 1,048,166 (Direct) | View |
| 2025-06-23 Other | 2025-06-25 5:13 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 56,665 | $8.21 | 156,816 (Direct) | View |
| 2025-05-25 Tax Withholding | 2025-05-27 4:08 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 2,202 | $5.68 | 88,348 (Direct) | View |
| 2025-05-25 Exercise | 2025-05-27 4:08 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 7,500 | $0 | 88,348 (Direct) | View |
| 2025-03-19 Other | 2025-03-20 4:06 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 20,000 | $6.155 | 120,151 (Direct) | View |
| 2025-02-09 Exercise | 2025-02-11 6:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 5,834 | $0 | 75,550 (Direct) | View |
| 2025-02-09 Exercise | 2025-02-11 6:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 20,000 | $0 | 332,325 (Direct) | View |
| 2025-02-09 Tax Withholding | 2025-02-11 6:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 2,055 | $6.495 | 100,151 (Direct) | View |
| 2025-02-09 Exercise | 2025-02-11 6:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 7,000 | $0 | 100,151 (Direct) | View |
| 2025-01-08 Option Award | 2025-01-08 4:14 pm | N/A 2035-01-08 | EyePoint Pharmaceuticals Inc. | EYPT | Sanders Reginald J. Director | 80,000 | $0 | 80,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:05 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:05 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | ANDO GORAN Director | 41,500 | $0 | 41,500 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | Duty Stuart Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | DICICCO WENDY F Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Ribeiro Ramiro Chief Medical Officer | 176,000 | $0 | 176,000 (Direct) | View |
| 2025-01-06 Tax Withholding | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 4,808 | $8.68 | 304,281 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 176,000 | $0 | 304,281 (Direct) | View |
| 2025-01-05 Exercise | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 30,285 | $0 | 304,281 (Direct) | View |
| 2025-01-05 Tax Withholding | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 5,267 | $8.26 | 304,281 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 40,000 | $0 | 452,791 (Direct) | View |
| 2025-01-05 Exercise | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 87,801 | $0 | 452,791 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:04 pm | 2026-01-03 2035-01-03 | EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director | 40,000 | $0 | 61,400 (Direct) | View |
| 2025-01-05 Exercise | 2025-01-07 4:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Landis John B. Director | 10,000 | $0 | 61,400 (Direct) | View |
| 2025-01-06 Tax Withholding | 2025-01-07 4:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 6,108 | $8.68 | 812,746 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 585,000 | $0 | 812,746 (Direct) | View |
| 2025-01-05 Exercise | 2025-01-07 4:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 50,794 | $0 | 812,746 (Direct) | View |
| 2025-01-05 Tax Withholding | 2025-01-07 4:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 10,007 | $8.26 | 812,746 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 4:02 pm | N/A 2034-09-03 | EyePoint Pharmaceuticals Inc. | EYPT | Hassan Fred Director | 60,000 | $0 | 60,000 (Direct) | View |
| 2024-07-26 Gift | 2024-07-26 4:47 pm | N/A 2030-02-28 | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Director | 262,574 | $0 | 1,045,966 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 11,625 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 11,625 (Direct) | View |
| 2024-07-12 Exercise | 2024-07-16 4:24 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 11,625 (Direct) | View |
| 2024-07-10 Tax Withholding | 2024-07-12 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 8,059 | $8.69 | 93,861 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:04 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 16,666 | $0 | 93,861 (Direct) | View |
| 2024-07-10 Exercise | 2024-07-12 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Lurker Nancy Executive Vice Chair | 11,111 | $0 | 243,574 (Direct) | View |
| 2024-07-11 Exercise | 2024-07-12 5:00 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Zaderej Karen L. Director | 2,000 | $0 | 6,000 (Direct) | View |
| 2024-06-23 Exercise | 2024-06-25 4:16 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | ADAMIS ANTHONY P Director | 2,000 | $0 | 6,000 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 23,250 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 23,250 (Direct) | View |
| 2024-06-03 Exercise | 2024-06-04 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 23,250 (Direct) | View |
| 2024-05-25 Tax Withholding | 2024-05-28 4:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 3,627 | $11.16 | 62,480 (Direct) | View |
| 2024-05-25 Exercise | 2024-05-28 4:22 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Elston George Chief Financial Officer | 7,500 | $0 | 62,480 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 3,250 | $3.5 | 34,875 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | 2024-02-23 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 9,775 | $0 | 34,875 (Direct) | View |
| 2024-05-14 Exercise | 2024-05-16 5:19 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | GUYER DAVID R Director | 6,525 | $3.26 | 34,875 (Direct) | View |
Ownership | 2024-04-22 4:15 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Adage Capital Management L.P. Atchinson Robert Gross Phillip 10% Owner | 0 | $0 | 5,156,299 (Indirect) | View |
| 2024-03-30 Tax Withholding | 2024-04-02 5:27 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 25,546 | $20.67 | 67,080 (Direct) | View |
| 2024-03-30 Exercise | 2024-04-02 5:27 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Paggiarino Dario A. Chief Medical Officer | 50,404 | $0 | 67,080 (Direct) | View |